Vimab Group AB (OSTO:VIMAB) Growth Rank: 1 (As of Sep. 21, 2026) — 83% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:VIMAB Vimab Group AB OSTO:VIMAB
57 GF Score
Price kr3.85
GF Value kr5.50
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Vimab Group AB Growth Rank?

Vimab Group AB OSTO:VIMAB 57 Growth Rank is 1 as of Sep. 21, 2026, which is 83% below its 10-year median of 6.00. GuruFocus rates OSTO:VIMAB with a GF Score™ of 57/100 and a GF Value™ of kr5.50 (Possible Value Trap). The stock has 4 warning signs investors should review.

Vimab Group AB has the Growth Rank of 1.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Vimab Group AB Growth Rank Related Terms

OSTO:VIMAB vs VRSK, EFX, BAH: Growth Rank Comparison

For the Consulting Services subindustry, Vimab Group AB's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vimab Group AB Growth Rank vs Business Services Industry

For the Business Services industry and Industrials sector, Vimab Group AB's Growth Rank distribution charts can be found below:

* The bar in red indicates where Vimab Group AB's Growth Rank falls into.


OSTO:VIMAB
57GF Score
Vimab Group AB OSTO:VIMAB
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 1 mean?
Vimab Group AB (OSTO:VIMAB) has a Growth Rank of 1 as of Sep. 21, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Vimab Group AB and its competitors. This is 83% below median its historical median of 6.00. Over the past decade, Vimab Group AB's Growth Rank has ranged from 1.00 to 8.00.
Is Vimab Group AB's Growth Rank too high?
Vimab Group AB's current Growth Rank of 1 is 83% below median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 8.00. Overall, Vimab Group AB has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vimab Group AB's Growth Rank compare to VRSK and EFX?
Vimab Group AB's Growth Rank of 1 can be compared against companies in the Business Services industry. Historically, Vimab Group AB's own Growth Rank has ranged from 1.00 to 8.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Business Services company?
A good Growth Rank depends on the Business Services industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Vimab Group AB and its competitors. Vimab Group AB's current Growth Rank is 1, which is 83% below median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vimab Group AB stock overvalued right now?
Based on GuruFocus' analysis, Vimab Group AB (OSTO:VIMAB) is currently considered Possible Value Trap. The stock's GF Value™ is kr5.50, compared to a current price of kr3.85 — trading 30% below its estimated fair value. The current Growth Rank is 1, which is 83% below median its 10-year median of 6.00. Vimab Group AB's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Vimab Group AB (OSTO:VIMAB), the current Growth Rank is 1 as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vimab Group AB (OSTO:VIMAB) Overvalued in 2026?

Based on GuruFocus' analysis, Vimab Group AB stock appears to be undervalued. The current stock price of kr3.85 is trading 30% below its estimated GF Value™ of kr5.50. GuruFocus considers Vimab Group AB to be Possible Value Trap.

Key valuation signals for OSTO:VIMAB:

  • Growth Rank: 1 (83% below median its 10-year median of 6.00)
  • GF Value™: kr5.50 vs. price of kr3.85 (30% below fair value)
  • GF Score™: 57/100 with 4 warning signs

No single metric tells the full story. See the OSTO:VIMAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vimab Group AB Business Description

Address Malmskillnadsgatan 40A, Stockholm, SWE, 111 57
Vimab Group AB is a Nordic company helping companies with transformation and improvement initiatives. It offers services including Interim management, Executive search.
57GF Score

Get the complete analysis for OSTO:VIMAB

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr3.85
Price
kr5.50
GF Value